Wednesday, October 8, 2008

Calistoga Pharmaceuticals Names CEO

Seattle-based Calistoga Pharmaceuticals said today that it has appointed Carol G. Gallagher, Pharm. D., as its CEO. According to Calistoga, Dr. Gallagher joins the firm from Metastatix, and has also served at Cancervax, Biogen Idec, Pfizer, Eli Lilly, Amgen, Agouron Pharmaceuticals, and Pfizer. Calistoga Pharmaceuticals is developing treatments for cancer and inflammatory disease; the firm is venture backed by Alta Partners, Amgen Ventures, Frazier Healthcare Ventures, Lilly Bioventures, and Three Arch Partners.